Position in VIR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,295,013
+$417,953 QoQ
Shares Held
256,140
-17.7% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Derivatives in VIR
reported options exposure · as of Dec 31, 2024CallValue
$284,058
CallShares
38,700
PutValue
$284,058
PutShares
38,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. VIR ranks #59 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in VIR
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,295,013 | 256,140 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,877,060 | 311,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,847,326 | 323,525 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,096,391 | 415,951 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,688,155 | 260,518 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,352,885 | 184,317 | Shares | Defined | 2025-02-12 | |
| 2024-12-31 | $284,058 | 38,700 | Put | Defined | 2025-02-12 | |
| 2024-12-31 | $284,058 | 38,700 | Call | Defined | 2025-02-12 | |
| 2024-09-30 | $856,989 | 114,418 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $755,351 | 84,871 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $11,393,524 | 1,124,731 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,072,570 | 206,021 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,412,334 | 257,453 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $3,838,404 | 156,478 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,959,986 | 299,097 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,876,249 | 192,661 | Shares | Defined | 2023-02-09 | |
| 2022-12-31 | $756,769 | 29,900 | Call | Defined | 2023-02-09 | |
| 2022-12-31 | $756,769 | 29,900 | Put | Defined | 2023-02-09 | |
| 2022-09-30 | $6,146,077 | 318,780 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,645,425 | 221,650 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,200,351 | 46,670 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,742,279 | 113,262 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,822,625 | 110,814 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,892,959 | 103,489 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,880,442 | 95,191 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $571,003 | 21,322 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $209,653 | 6,107 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $446,859 | 10,907 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $90,644 | 2,645 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||